Description
BLOOD AND BLOOD PRODUCTS
First action · last action
2017-03-01 · 2018-05-17
Transactions
2
First transaction's obligation
$480,000
Base + all options value (sum of deltas)
$377,524
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25017D0043
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-03-01+$480,000= $480,000
- Mod P000012018-05-17-$102,476= $377,524
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-03-01 | +$480,000 | $480,000 | BLOOD AND BLOOD PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2018-05-17 | −$102,476 | $377,524 | BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DZ4YCZ3QSPR5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0503 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $23,896 | FY2026 |
| 36C25026P0345 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $300,000 | FY2026 |
| 36C25025P1761 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6910 · TRAINING AIDS | $5,000 | FY2025 |
| 36C25025C0078 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6506 · BLOOD AND BLOOD PRODUCTS | $300,000 | FY2025 |
| 36C24E24P0023 | RPO EAST (36C24E) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $6,086 | FY2024 |
| 36C25024C0070 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $215,752 | FY2024 |
Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026P0991 | ASD SPECIALTY HEALTHCARE, LLC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $43,680 | FY2026 |
| 36C25026F0668 | COSETTE PHARMACEUTICALS, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $10,398 | FY2026 |
| 36C25026N0655 | PROGENICS PHARMACEUTICALS INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $721,744 | FY2026 |
| 36C25026N0616 | AMERICAN NATIONAL RED CROSS, THE | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $37,180 | FY2026 |
| 36C25026D0061 | AMERICAN NATIONAL RED CROSS, THE | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25017J2137_3600_VA25017D0043_3600 · retrieved 2026-09-26.